Literature DB >> 1977070

Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.

S J Li1, H K Jiang, M S Stachowiak, P M Hudson, V Owyang, K Nanry, H A Tilson, J S Hong.   

Abstract

The purpose of this study was to obtain direct evidence that the nigrostriatal dopamine (DA) pathway modulates the metabolism of striatal dynorphin and [Met5]-enkephalin. This was achieved by repeated injections of apomorphine (APO) or D-amphetamine (AMP) in unilateral nigral 6-hydroxydopamine (6-OHDA)-lesioned rats. Three weeks after a 6-OHDA lesion, dynorphin A(1-8)-like immunoreactivity (DN-LI) and the level of mRNA encoding prodynorphin in the striatum on the lesioned side were decreased compared with the contralateral control side. Activation of DA receptors by 7 daily injections of APO (5 mg/kg, Bid, s.c.), however, caused a large increase (3- to 4-fold of saline control) in striatal levels of DN-LI and prodynorphin mRNA on the 6-OHDA lesioned side, which is far greater than the increase on the contralateral side (2-fold of saline control). Presumably, the potentiated effect of APO in 6-OHDA lesioned rats is due to hypersensitivity of DA receptors resulting from DA denervation. Seven daily injections of AMP (5 mg/kg, Bid, s.c.), a DA-releasing agent, increased striatal DN-LI (187% of saline control) on the non-lesioned side, but not on the 6-OHDA-lesioned side. Taken together, the data indicate that the nigrostriatal pathway exerts a tonic excitatory influence over the biosynthesis of dynorphin and that this influence is not maximal since an additional increase in dopaminergic tone further increases the expression of dynorphin. In contrast, [Met5]-enkephalin-like immunoreactivity (ME-LI) in the striatum was increased by a 6-OHDA-lesion (145% of contralateral control), which was blocked by repeated administration of APO but not AMP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977070     DOI: 10.1016/0169-328x(90)90020-e

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Striatal enkephalinergic differences in rats selectively bred for intrinsic running capacity.

Authors:  Derek C Monroe; Philip V Holmes; Lauren G Koch; Steven L Britton; Rodney K Dishman
Journal:  Brain Res       Date:  2014-05-17       Impact factor: 3.252

3.  Trichloroethylene and Parkinson's Disease: Risk Assessment.

Authors:  Mei Liu; Eun-Joo Shin; Duy-Khanh Dang; Chun-Hui Jin; Phil Ho Lee; Ji Hoon Jeong; Seok-Joo Park; Yong-Sun Kim; Bin Xing; Tao Xin; Guoying Bing; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2017-12-22       Impact factor: 5.590

4.  Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  B Henry; J M Brotchie
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

5.  Preproenkephalin promoter "cassette" confers brain expression and synaptic regulation in transgenic mice.

Authors:  D M Donovan; M Takemura; B F O'Hara; M T Brannock; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

6.  The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.

Authors:  I Nylander; M Vlaskovska; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

7.  Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.

Authors:  R Granata; G K Wenning; J Jolkkonen; P Jenner; C D Marsden
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 8.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

9.  Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.

Authors:  Jean Lud Cadet; Christie Brannock; Irina N Krasnova; Bruce Ladenheim; Michael T McCoy; Jenny Chou; Elin Lehrmann; William H Wood; Kevin G Becker; Yun Wang
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.